Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison

• Mazyar Shadman,
• Alessandra Tedeschi,
• Leyla Mohseninejad,
• Keri Yang,
• Nicole Lamanna,
• Sheng Xu,
• Aileen Cohen,
• Swetha Challagulla,
• Mei Xue,
• Rhys Williams,
• Susan M. O’Brien,
• Jennifer R. Brown,
• Constantine Tam

Affiliations

Mazyar Shadman

Fred Hutchinson Cancer Research Center and University of Washington

Alessandra Tedeschi

ASST Grande Ospedale Metropolitano Niguarda

Leyla Mohseninejad

BeiGene, Netherlands B.V.

Keri Yang

BeiGene USA Inc

Nicole Lamanna

Herbert Irving Comprehensive Cancer Center, Columbia University

Sheng Xu

BeiGene (Beijing) Co. Ltd.

Aileen Cohen

BeiGene USA Inc

Swetha Challagulla

BeiGene USA Inc

Mei Xue

BeiGene USA Inc

Rhys Williams

BeiGene USA Inc

Susan M. O’Brien

Chao Family Comprehensive Cancer Center, University of California

Jennifer R. Brown

Dana–Farber Cancer Institute

Constantine Tam

The Alfred Hospital and Monash University